- $926.00m
- $880.48m
- $580.62m
- 84
- 42
- 87
- 82
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 455 | 490 | 578 | 582 | 581 |
Cost of Revenue | |||||
Gross Profit | 61.6 | 52.5 | 70.5 | 53.7 | 48.5 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 444 | 484 | 548 | 587 | 601 |
Operating Profit | 10.7 | 6.21 | 30.5 | -4.72 | -20.8 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 10.7 | 18.7 | 29.3 | -5.76 | -21.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | 62.5 | 18.1 | 23.6 | -5.25 | -68.9 |
Net Income Before Extraordinary Items | |||||
Net Income | 62.5 | 18.1 | 23.6 | -5.25 | -68.9 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 62.5 | 18.1 | 23.6 | -5.25 | -68.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.18 | 0.126 | 0.216 | -0.088 | -1.28 |